Financials

  • Market Capitalization 75.73 M
  • Employee 54
  • Founded 2013
  • CEO N/A
  • Website www.pmvpharma.com
  • Headquarter Delaware, United States
  • FIGI BBG007NM47G3
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.84
Rapporto prezzo/fatturato
12.2

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4096
RNTX
Rein Therapeutics, Inc. - Common Stock
0.92 USD+1.10%-7.07%-8.00%-16.39%78.70 M USD
4097
CSBR
Champions Oncology, Inc. - Common Stock
5.66 USD-2.58%-5.98%-10.73%-27.53%78.60 M USD
4140
ATRA
Atara Biotherapeutics, Inc. - Common Stock
8.04 USD-7.27%-19.92%-18.95%-45.49%72.44 M USD
4143
GANX
Gain Therapeutics, Inc. - Common Stock
1.68 USD-4.55%-5.62%-5.62%+7.01%71.66 M USD

Notizie